Updated on 9 September 2026
Pre-IPO round investment
Director at RobotVision
China (Hong Kong)
About
Robotvision is a Shenzhen‑based high‑tech manufacturer founded in 2014, building high‑precision machine‑vision inspection and metrology equipment for semiconductors, displays, consumer electronics, new‑energy and automotive industries.
We have proprietary hardware‑software integrated vision technology, and serve leading global supply‑chain customers. We focus on semiconductor metrology equipment localization and global business development.
Project Location
- China
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Investment / Financing Discussion
Main Project Sector
- Manufacturing
Investment Capital Required
- 50,000,001 USD or above
Type(s) of Last Financing Round of the project (if Applicable)
- Equity (private)
Total amount raised (USD)
30000000
Main Service(s) Required
- Professional Services
Similar opportunities
Project
Aden OTC Assets Electronic Trading Platform
- No
- Yes
- Equity
- Fin-Tech
- Technology
- Securities
- Private Project
- Equity (private)
- Wealth Management
- Financial Services
- Minority Shareholdings
- 50,000,001 USD or above
- Direct Equity Investment
- 25,000,001 to 50,000,000 USD
- Investment / Financing Discussion
CHENG CHEN
Co-Founder at ADEN GROUP
China (Hong Kong)
Project
Hong Kong Pioneering Radiopharmaceutical Project
- Yes
- Yes
- Technology
- Operations
- Private Project
- Equity (private)
- Professional Services
- 50,000,001 USD or above
- Direct Equity Investment
- 10,000,001 to 25,000,000 USD
Yuk Man Chan
Corporate development at ZERO Biotech Co. Ltd
China (Hong Kong)
Project
A First-in-Class Antivirulence Drug for the Treatment of Eczema (Atopic Dermatitis)
- No
- Yes
- Equity
- Bio-Tech
- Technology
- Private Project
- Equity (private)
- Professional Services
- Minority Shareholdings
- 50,000,001 USD or above
- Direct Equity Investment
- 5,000,001 to 7,500,000 USD
- Risk Management & Resilience
- Private Equity & Venture Capital
- Investment / Financing Discussion
Thomas Lee
Chief Operating Officer at Antenovus Biotechnology Limited
China (Hong Kong)